Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NTGCNSX:VPNYSEARCA:ZIG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNTGTortoise Midstream Energy Fund$53.36$54.39$39.22▼$59.45N/AN/A12,895 shs24,436 shsVPVodis Pharmaceuticals$0.00$0.16▼$0.62N/AN/A1,714 shs51,582 shsZIGThe Acquirers Fund$34.36+0.9%$33.27$29.44▼$43.79$34.36M1.024,374 shs1,589 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNTGTortoise Midstream Energy Fund0.00%0.00%0.00%0.00%+33.45%VPVodis Pharmaceuticals0.00%0.00%0.00%0.00%0.00%ZIGThe Acquirers Fund0.00%+2.17%+2.02%-2.36%-6.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNTGTortoise Midstream Energy FundN/AN/AN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AZIGThe Acquirers FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNTGTortoise Midstream Energy Fund 0.00N/AN/AN/AVPVodis Pharmaceuticals 0.00N/AN/AN/AZIGThe Acquirers Fund 2.44Hold$34.36N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNTGTortoise Midstream Energy Fund$75.79MN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AZIGThe Acquirers FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNTGTortoise Midstream Energy FundN/A-$0.03N/A∞N/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/AZIGThe Acquirers FundN/AN/A8.81∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNTGTortoise Midstream Energy Fund$3.165.92%N/AN/A N/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AZIGThe Acquirers Fund$0.722.10%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNTGTortoise Midstream Energy FundN/AVPVodis PharmaceuticalsN/AZIGThe Acquirers FundN/AInsider OwnershipCompanyInsider OwnershipNTGTortoise Midstream Energy FundN/AVPVodis PharmaceuticalsN/AZIGThe Acquirers FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNTGTortoise Midstream Energy FundN/AN/AN/ANot OptionableVPVodis PharmaceuticalsN/AN/AN/ANot OptionableZIGThe Acquirers FundN/A1.00 millionN/ANot OptionableASY, ZIG, NTG, and VP HeadlinesRecent News About These Companies(ZIG) Trading AdviceFebruary 10, 2025 | news.stocktradersdaily.comHow to Take Advantage of moves in (ZIG)January 8, 2025 | news.stocktradersdaily.comThe Acquirers Fund ETF declares annual distribution of $0.3731December 30, 2024 | seekingalpha.com(ZIG) Long Term Investment AnalysisDecember 29, 2024 | news.stocktradersdaily.com(ZIG) Investment Analysis and AdviceDecember 8, 2024 | news.stocktradersdaily.comWhen (ZIG) Moves Investors should ListenNovember 5, 2024 | news.stocktradersdaily.comTrading (ZIG) With Integrated Risk ControlsOctober 25, 2024 | news.stocktradersdaily.com(ZIG) Technical DataOctober 17, 2024 | news.stocktradersdaily.com(ZIG) On The My Stocks PageOctober 4, 2024 | news.stocktradersdaily.com(ZIG) Pivots Trading Plans and Risk ControlsSeptember 23, 2024 | news.stocktradersdaily.com'Time to be patient': A top fund manager shares why he's hoarding cash, betting big on gold, and shying away from AISeptember 9, 2024 | businessinsider.com(ZIG) Technical Pivots with Risk ControlsAugust 28, 2024 | news.stocktradersdaily.comWhy Is Fashion Retailer Buckle Stock Gaining Today?August 23, 2024 | benzinga.comWilliam Blair SICAV Emerging Markets Frontier Debt FundAugust 15, 2024 | bloomberg.com4 months in, the Zimbabwe ZiG currency (ZWG) is holding on wellAugust 14, 2024 | msn.comThe Acquirers Fund (ARCA:ZIG), Short Interest ReportJune 9, 2022 | benzinga.comU.S. Merchant Acquiring Markets 2022: New Trends Emerge as Declining Demand for Traditional Acquiring - ResearchAndMarkets.comFebruary 3, 2022 | finance.yahoo.com3 Trades On PulteGroup Stock Ahead Of The Homebuilder’s Q4 ReportJanuary 26, 2022 | msn.com5 ETFs That Survived the Last Week's RoutDecember 6, 2021 | finance.yahoo.comTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Underrated Stocks Quietly Delivering Big GainsBy Thomas Hughes | May 13, 2025View 3 Underrated Stocks Quietly Delivering Big GainsThese ETFs Provide Easy Exposure to Growing International MarketsBy Nathan Reiff | May 24, 2025View These ETFs Provide Easy Exposure to Growing International MarketsASY, ZIG, NTG, and VP Company DescriptionsTortoise Midstream Energy Fund NYSE:NTGTortoise MLP Fund, Inc. is a close ended equity mutual fund launched and managed by Tortoise Capital Advisors L.L.C. It invests in public equity markets. The fund primarily invests in equity securities of MLPs and their affiliates, with an emphasis on natural gas infrastructure Master Limited Partnerships. It employs a fundamental analysis with a bottom up stock picking approach with focus on factors like quantitative, qualitative, and relative value factors to create its portfolio. Tortoise MLP Fund, Inc. was formed on July 27, 2010 is domiciled in United States.Vodis Pharmaceuticals CNSX:VPVodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.The Acquirers Fund NYSEARCA:ZIG$34.36 +0.31 (+0.91%) As of 06/6/2025 04:10 PM EasternThe Acquirers Fund ETF (ZIG) is an exchange-traded fund that is based on the ZIG-US - No underlying index. The fund is an actively-managed portfolio of equity securities issued by US-listed companies that exhibit strong fundamentals and value characteristics. ZIG was launched on May 15, 2019 and is managed by Acquirers Fund. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/02 - 06/06 This Banking Giant Just Got a $90 Price Target Upgrade Broadcom Slides on Solid Earnings, AI Outlook Still Strong The Market’s Silent Warning: What Bonds and Gold Reveal Intel's Dual Gamble: AI Innovation Now, Foundry Fortunes Later? MongoDB Affirms Outlook and Accelerates Stock Price Reversal Five Below Pops on Strong Earnings, But Rally May Stall Are NVIDIA's Ethernet Wins Signs of Hope or Horror for Arista? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
